Clinical lung cancer 2018-07
Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease.
Related Questions
Specifically in O2-dependent patients? Have any dose/fractionation regimens been shown to reduce the risk of pneumonitis in this population?
New answer by Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System (October 11, 2023)
I will only treat these patients with DIBH or Gated techniques. The risks are too high to allow SBRT doses to treat a bunch of normal lung parenchyma that move in and out of a...